[HTML][HTML] The immunology of SARS-CoV-2 infections and vaccines
L Grigoryan, B Pulendran - Seminars in immunology, 2020 - Elsevier
Abstract SARS-CoV-2, the virus that causes COVID-19, emerged in late 2019, and was
declared a global pandemic on March 11th 2020. With over 50 million cases and 1.2 million …
declared a global pandemic on March 11th 2020. With over 50 million cases and 1.2 million …
[HTML][HTML] A Research and Development (R&D) roadmap for influenza vaccines: Looking toward the future
KA Moore, JT Ostrowsky, AM Kraigsley, AJ Mehr… - Vaccine, 2021 - Elsevier
Improved influenza vaccines are urgently needed to reduce the burden of seasonal
influenza and to ensure a rapid and effective public-health response to future influenza …
influenza and to ensure a rapid and effective public-health response to future influenza …
The role of cell-mediated immunity against influenza and its implications for vaccine evaluation
Y Janssens, J Joye, G Waerlop, F Clement… - Frontiers in …, 2022 - frontiersin.org
Influenza vaccines remain the most effective tools to prevent flu and its complications.
Trivalent or quadrivalent inactivated influenza vaccines primarily elicit antibodies towards …
Trivalent or quadrivalent inactivated influenza vaccines primarily elicit antibodies towards …
Immunosenescence and altered vaccine efficiency in older subjects: A myth difficult to change
Organismal ageing is associated with many physiological changes, including differences in
the immune system of most animals. These differences are often considered to be a key …
the immune system of most animals. These differences are often considered to be a key …
The status and prospects of Epstein–Barr virus prophylactic vaccine development
Epstein–Barr virus (EBV) is a human herpesvirus that is common among the global
population, causing an enormous disease burden. EBV can directly cause infectious …
population, causing an enormous disease burden. EBV can directly cause infectious …
Env exceptionalism: why are HIV-1 Env glycoproteins atypical immunogens?
PJ Klasse, G Ozorowski, RW Sanders, JP Moore - Cell host & microbe, 2020 - cell.com
Recombinant HIV-1 envelope (Env) glycoproteins of ever-increasing sophistication have
been evaluated as vaccine candidates for over 30 years. Structurally defined mimics of …
been evaluated as vaccine candidates for over 30 years. Structurally defined mimics of …
Distinct immunological and molecular signatures underpinning influenza vaccine responsiveness in the elderly
P Riese, S Trittel, MK Akmatov, M May… - Nature …, 2022 - nature.com
Seasonal influenza outbreaks, especially in high-risk groups such as the elderly, represent
an important public health problem. Prevailing inadequate efficacy of seasonal vaccines is a …
an important public health problem. Prevailing inadequate efficacy of seasonal vaccines is a …
The effect of influenza vaccine in reducing the severity of clinical outcomes in patients with COVID-19: a systematic review and meta-analysis
Recent evidence suggests that vaccination against influenza may reduce the clinical
outcomes of COVID-19. This study looked at the link between influenza vaccination and the …
outcomes of COVID-19. This study looked at the link between influenza vaccination and the …
Rational vaccine design in times of emerging diseases: The critical choices of immunological correlates of protection, vaccine antigen and immunomodulation
Vaccines are the most effective medical intervention due to their continual success in
preventing infections and improving mortality worldwide. Early vaccines were developed …
preventing infections and improving mortality worldwide. Early vaccines were developed …
Prophylactic and therapeutic ebv vaccines: Major scientific obstacles, historical progress, and future direction
The Epstein-Barr virus (EBV) infects more than 95% of adults worldwide and is associated
with various malignant tumors and immune diseases, imparting a huge disease burden on …
with various malignant tumors and immune diseases, imparting a huge disease burden on …